Laboratory Corporation Of America Holdings

CLIA Laboratory Citation Details

2
Total Citations
8
Total Deficiencyies
4
Unique D-Tags
CMS Certification Number 49D0967342
Address 6130 Harbourside Centre Loop - Suite 101, Midlothian, VA, 23112
City Midlothian
State VA
Zip Code23112
Phone804 739-3479
Lab DirectorREENA JAIN

Citation History (2 surveys)

Survey - May 8, 2025

Survey Type: Standard

Survey Event ID: 916Q11

Deficiency Tags: D0000 D6127 D6128 D0000 D6127 D6128

Summary:

Summary Statement of Deficiencies D0000 An announced CLIA recertification survey was conducted at Laboratory Corporation of America on May 7-8, 2025 by the Virginia Department of Health's Office of Licensure and Certification. The laboratory was surveyed under 42 CFR part 493 CLIA Regulations. The specific deficiencies cited are as follows: D6127 TECHNICAL SUPERVISOR RESPONSIBILITIES CFR(s): 493.1451(b)(9) (b)(9) Evaluating and documenting the performance of individuals responsible for high complexity testing at least semiannually during the first year the individual tests patient specimens. This STANDARD is not met as evidenced by: Based on a review of Centers for Medicare and Medicaid Services Laboratory Personnel Report form (CMS 209), laboratory's personnel files, laboratory's policies and procedures, lack of documentation, and an interview, the Technical Supervisor (TS) failed to follow the established laboratory policy to perform a six month Hematology and Chemistry competency evaluations for three (3) of five (5) testing personnel in calendar year 2023 until the dates of the survey on May 7-8, 2025. The findings include: 1. Review of the CMS 209 form revealed that the laboratory director identified one Technical Supervisor (TS), one General Supervisor and 5 testing personnel (TP) responsible for high complexity Hematology and Chemistry testing. 2. Review of the laboratory's policies and procedures revealed a policy, "Training and Competency Assessment Policy", with the following statement, "Competency...4. "For non-waived test systems, all the above six elements must be assessed following initial training, six months after initial training, then annually (unless any are not applicable to the test system)..." 3. Review of the laboratory's personnel files revealed TP C was hired on January 9, 2023 with an initial competency record completed on January 30, 2023. The surveyor requested to review a semi-annual competency Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- assessment for TP C completed in July 2023. The laboratory provided competencies completed on December 11, 2023 and December 30, 2024. (See Personnel Code Sheet.) 4. Review of the laboratory's personnel files revealed TP D was hired on August 14, 2023 with an initial competency record for TP D completed on October 30, 2023. The surveyor request to review a semi-annual competency assessment for TP D completed in April 2024. The laboratory provided competencies completed on July 1, 2024 and December 5, 2024. (See Personnel Code Sheet.) 5. Review of the laboratory's personnel files revealed TP E was hired on April 24, 2023 with an initial competency record for TP E completed on July 28, 2023. The surveyor requested to review a semi-annual competency assessment for TP E completed in February 2024. The laboratory provided competencies completed on June 7, 2024 and December 5, 2024. (See Personnel Code Sheet.) 6. In an exit interview with the Technical Supervisor on May 8, 2025 at 9:00 AM, the above findings were confirmed. D6128 TECHNICAL SUPERVISOR RESPONSIBILITIES CFR(s): 493.1451(b)(9) (b)(9) Thereafter, evaluations must be performed at least annually unless test methodology or instrumentation changes, in which case, prior to reporting patient test results, the individuals performance must be reevaluated to include the use of the new test methodology or instrumentation. This STANDARD is not met as evidenced by: Based on a review of the Centers for Medicare and Medicaid Services Laboratory Personnel Report form (CMS 209), laboratory's personnel files, laboratory's policies and procedures, lack of documentation, and interview, the technical supervisor (TS) failed to follow their established policy and perform annual competency assessment evaluations for one (1) of five (5) testing personnel responsible performing high complexity Hematology and Chemistry testing in calendar year 2023. The findings include: 1. Review of the CMS 209 form revealed that the laboratory director identified one Technical Supervisor, one General Supervisor and five testing personnel (TP) responsible for high complexity Hematology and Chemistry testing. 2. Review of the laboratory's personnel files revealed TP B was hired on May 23, 2022 with an initial competency record for TP B completed on June 14, 2022 and semi- annual competency performed on November 4, 2022. The surveyor requested to review an annual competency assessment for TP B completed in 2023. The laboratory provided competencies completed on January 12, 2024 and December 30, 2024 for review. (See Personnel Code Sheet.) 3. Review of the laboratory's policies and procedures revealed a policy, "Training and Competency Assessment Policy", with the following statement, "Competency...4. "For non-waived test systems, all the above six elements must be assessed following initial training, six months after initial training, then annually (unless any are not applicable to the test system)..." 4. In an exit interview with the Technical Supervisor on May 8, 2025 at 9:00 AM, the above findings were confirmed. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - April 25, 2023

Survey Type: Standard

Survey Event ID: DGIB11

Deficiency Tags: D0000 D5447

Summary:

Summary Statement of Deficiencies D0000 An announced CLIA Recertification survey was conducted at the Laboratory Corporation of America Holdings on 04/25/23 by the Virginia Department of Health's Office of Licensure and Certification. The laboratory was surveyed under 42 CFR part 493 CLIA Requirements. Specific deficiencies cited are as follows: D5447 CONTROL PROCEDURES CFR(s): 493.1256(d)(3)(i)(g) Unless CMS Approves a procedure, specified in Appendix C of the State Operations Manual (CMS Pub. 7), that provides equivalent quality testing, the laboratory must-- At least once a day patient specimens are assayed or examined perform the following for-- Each quantitative procedure, include two control materials of different concentrations; (g) The laboratory must document all control procedures performed. This STANDARD is not met as evidenced by: Based on the review of quality control records (QC), policy and procedures (P&P), lack of documentation, daily patient testing logs and interview, the lab failed to follow the established P&P ensuring QC levels were within acceptable range and

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access